(b)(4).- although there were reportedly no impact to the patient, the event description indicates an estimated amount of volume of blood loss was 600ml.The actual device was returned to the manufacturing facility and evaluated.Visual inspection of the actual sample upon receipt found the formation of thrombus on the surface of the filter.The actual sample was rinsed, dried and built into a circuit with tubes, where bovine blood was filled and then circulated at each flow rate to determine the pressure drop.The obtained values were verified to be within the specifications.The bovine blood was kept circulated in the circuit for 6 hours, no anomaly was noted.The pump record from the involved procedure was reviewed.An increase in the pressure and a decrease in the temperature were noted.A review of the blood date did not find any anomaly which could definitely relate to the increase in the pressure.A review of the manufacturing record and product release decision control sheet of the involved product/lot# combination confirmed there were no indications of production-related anomalies.A search of the complaint file found no other similar complaint with the involved product/lot# combination.Based upon the available information, the cause for the reported event cannot be definitively determined.There are many complex clinical variables that may have affected the reportedly observed conditions during the procedure.However, there is no indication that the reported event was related to a product malfunction or defect.All currently available information has been placed on file by qa at the manufacturing facility for appropriate tracking, trending, and follow up.(b)(4).
|